CELZ

Creative Medical Technology Holdings, Inc.

Insider Trades

Name	Value	Action	Price	Current Price
Finger Michael H.Director $4.3k750 shares SellFeb 19, 2025 $5.75 --
Finger Michael H.Director $3.8k750 shares SellFeb 18, 2025 $5.00 --

News

proactiveinvestors.comCreative Medical Technology opens nationwide burn-pit data registryproactiveinvestors.comJun 16

globenewswire.comCreative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazardsglobenewswire.comJun 16

globenewswire.comCreative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapiesglobenewswire.comApr 28

Trade CELZ

About Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.

CEO: Timothy Warbington
IPO Date: Nov 6, 2015

Market Data

Open: $2.22
High: $2.32
Low: $2.21
Volume: 94.1K
Avg Volume: 65.1K
52W High: $6.25
52W Low: $1.50

Valuation

Market Cap: $5.8M
Enterprise Value: $32k
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-5.9M
Revenue: $6.0k
Net Income: $-6.0M
Cash: $7.2M
Debt: $0

Events

EarningsAug 14

EPS est. -0.39